Spectrum Pharmaceuticals
Patents, Design & Utilities

Last updated:

List of all Spectrum Pharmaceuticals patents 10 in total

Status Patent
Grant
Utility: Combination therapy using belinostat and pralatrexate to treat lymphoma External link
Filling date: 6 Sep 2025 Issue date: 13 Sep 2022
Application
Utility: Methods of Treatment Using G-CSF Protein Complex External link
Filling date: 6 Sep 2025 Issue date: 19 May 2022
Grant
Utility: Methods of treatment using G-CSF protein complex External link
Filling date: 6 Sep 2025 Issue date: 8 Mar 2022
Application
Utility: KITS AND METHODS FOR TREATING CANCERS External link
Filling date: 6 Sep 2025 Issue date: 10 Feb 2022
Application
Utility: METHODS OF TREATING CHEMOTHERAPY INDUCED NEUTROPENIA USING FIXED DOSES OF G-CSF PROTEIN COMPLEX External link
Filling date: 6 Sep 2025 Issue date: 20 Jan 2022
Application
Utility: NOVEL QUINAZOLINE EGFR INHIBITORS External link
Filling date: 6 Sep 2025 Issue date: 18 Nov 2021
Application
Utility: POZIOTINIB COMBINATIONS WITH AN ANTI-HER1, HER2 OR HER4 ANTIBODY AND METHODS OF USE THEREOF External link
Filling date: 6 Sep 2025 Issue date: 26 Aug 2021
Application
Utility: COMBINATION OF POZIOTINIB WITH CYTOTOXIC AGENT AND/OR OTHER MOLECULARLY TARGETED AGENT AND USE THEREOF External link
Filling date: 6 Sep 2025 Issue date: 20 May 2021
Application
Utility: NOVEL METHODS OF TREATING NEUTORPENIA USING G-CSF PROTEIN COMPLEX External link
Filling date: 6 Sep 2025 Issue date: 14 Jan 2021
Application
Utility: INHIBITORS OF MUTANT FAMILY TYROSINE-KINASES External link
Filling date: 6 Sep 2025 Issue date: 20 Aug 2020

Showing 1 to 10 of 10 patents.